Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Radius Health
Radius Health
(RDUS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tymlos
Abaloparatide
2017-04-28
2027-2040
Osteoporosis
,
Postmenopausal osteoporosis
Binosto
Alendronic acid
2012-03-12
2031
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
,
Postmenopausal osteoporosis
,
Hypoparathyroidism
,
Extramammary paget disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alendronic acid
bone diseases
,
osteitis deformans
,
vitamin d deficiency
,
osteoporosis
,
postmenopausal osteoporosis
,
esophageal neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
Abaloparatide
healthy volunteers/patients
,
metabolic bone diseases
,
motor activity
,
osteoporotic fractures
,
osteoporosis
,
postmenopausal osteoporosis
,
bone fractures
,
femoral fractures
,
distal femoral fractures
,
replacement arthroplasty knee
Aspartame
leukemia
,
myeloid leukemia
,
ulcerative colitis
,
colitis
,
ulcer
,
rheumatoid arthritis
,
myeloid leukemia acute
,
atopic dermatitis
,
hidradenitis suppurativa
,
eczema
,
dermatitis
,
crohn disease
,
pathologic constriction
,
inflammatory bowel diseases
,
intestinal diseases
Bevifimod
adenocarcinoma
,
prostatic neoplasms
Globulin, immune
lymphoma
Nabiximols
neoplasms
,
oncogenes
Rad011
prader-willi syndrome
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use